Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 201762
Company: ACTAVIS GRP PTC
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 25MG BASE TABLET;ORAL Discontinued None No No
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 50MG BASE TABLET;ORAL Discontinued None No No
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 100MG BASE TABLET;ORAL Discontinued None No No
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 150MG BASE TABLET;ORAL Discontinued None No No
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 200MG BASE TABLET;ORAL Discontinued None No No
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 300MG BASE TABLET;ORAL Discontinued None No No
QUETIAPINE FUMARATE QUETIAPINE FUMARATE EQ 400MG BASE TABLET;ORAL Discontinued None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
02/27/2013 ORIG-1 Approval Not Applicable

Label is not available on this site.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English